SCPH

scPharmaceuticals Inc. - Common Stock (SCPH)

About scPharmaceuticals Inc. - Common Stock (SCPH)

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Details

Daily high

$3.88

Daily low

$3.71

Price at open

$3.84

52 Week High

$5.65

52 Week Low

$1.94

Market cap

202.7M

Dividend yield

0.00%

Volume

218,360

Avg. volume

304,999

P/E ratio

-2.01

scPharmaceuticals Inc. - Common Stock News